Clinical protocol for a double-blind, randomized, active- controlled comparison study of the antihypertensive effect of eplerenone versus losartan in patients with mild to moderate hypertension.

Trial Profile

Clinical protocol for a double-blind, randomized, active- controlled comparison study of the antihypertensive effect of eplerenone versus losartan in patients with mild to moderate hypertension.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 04 Dec 2009

At a glance

  • Drugs Eplerenone; Losartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 24 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top